These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

245 related articles for article (PubMed ID: 23474763)

  • 21. Identification of biomarkers that distinguish human papillomavirus (HPV)-positive versus HPV-negative head and neck cancers in a mouse model.
    Strati K; Pitot HC; Lambert PF
    Proc Natl Acad Sci U S A; 2006 Sep; 103(38):14152-7. PubMed ID: 16959885
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Hyaluronan-CD44 interaction promotes HPV 16 E6 oncogene-mediated oropharyngeal cell carcinoma survival and chemoresistance.
    Bourguignon LYW; Earle C; Shiina M
    Matrix Biol; 2019 May; 78-79():180-200. PubMed ID: 30077625
    [TBL] [Abstract][Full Text] [Related]  

  • 23. E6 oncoprotein represses p53-dependent gene activation via inhibition of protein acetylation independently of inducing p53 degradation.
    Thomas MC; Chiang CM
    Mol Cell; 2005 Jan; 17(2):251-64. PubMed ID: 15664194
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The molecular mechanism of human papillomavirus-induced carcinogenesis in head and neck squamous cell carcinoma.
    Sano D; Oridate N
    Int J Clin Oncol; 2016 Oct; 21(5):819-826. PubMed ID: 27339270
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Does the expression of HPV16/18 E6/E7 in head and neck squamous cell carcinomas relate to their clinicopathological characteristics?
    Yamakawa-Kakuta Y; Kawamata H; Doi Y; Fujimori T; Imai Y
    Int J Oncol; 2009 Nov; 35(5):983-8. PubMed ID: 19787251
    [TBL] [Abstract][Full Text] [Related]  

  • 26. HPV 5 and 8 E6 abrogate ATR activity resulting in increased persistence of UVB induced DNA damage.
    Wallace NA; Robinson K; Howie HL; Galloway DA
    PLoS Pathog; 2012; 8(7):e1002807. PubMed ID: 22807682
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Immortalization of oral keratinocytes by functional inactivation of the p53 and pRb pathways.
    Smeets SJ; van der Plas M; Schaaij-Visser TB; van Veen EA; van Meerloo J; Braakhuis BJ; Steenbergen RD; Brakenhoff RH
    Int J Cancer; 2011 Apr; 128(7):1596-605. PubMed ID: 20499310
    [TBL] [Abstract][Full Text] [Related]  

  • 28. SLC7A11 as a biomarker and therapeutic target in HPV-positive head and neck Squamous Cell Carcinoma.
    Hémon A; Louandre C; Lailler C; Godin C; Bottelin M; Morel V; François C; Galmiche A; Saidak Z
    Biochem Biophys Res Commun; 2020 Dec; 533(4):1083-1087. PubMed ID: 33019976
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Relationship between HPV16/18 E6 and 53, 21WAF1, MDM2, Ki67 and cyclin D1 expression in esophageal squamous cell carcinoma: comparative study by using tissue microarray technology.
    Qi ZL; Huo X; Xu XJ; Zhang B; Du MG; Yang HW; Zheng LK; Li J; Shen ZY
    Exp Oncol; 2006 Sep; 28(3):235-40. PubMed ID: 17080019
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A subset of head and neck squamous cell carcinomas exhibits integration of HPV 16/18 DNA and overexpression of p16INK4A and p53 in the absence of mutations in p53 exons 5-8.
    Hafkamp HC; Speel EJ; Haesevoets A; Bot FJ; Dinjens WN; Ramaekers FC; Hopman AH; Manni JJ
    Int J Cancer; 2003 Nov; 107(3):394-400. PubMed ID: 14506739
    [TBL] [Abstract][Full Text] [Related]  

  • 31. High frequency of HPV16-associated head and neck squamous cell carcinoma in the Puerto Rican population.
    Báez A; Almodóvar JI; Cantor A; Celestin F; Cruz-Cruz L; Fonseca S; Trinidad-Pinedo J; Vega W
    Head Neck; 2004 Sep; 26(9):778-84. PubMed ID: 15350023
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Expression of human papillomavirus oncoproteins E6 and E7 inhibits invadopodia activity but promotes cell migration in HPV-positive head and neck squamous cell carcinoma cells.
    Kahue CN; Jerrell RJ; Parekh A
    Cancer Rep (Hoboken); 2018 Oct; 1(3):e1125. PubMed ID: 32721084
    [TBL] [Abstract][Full Text] [Related]  

  • 33. NRF2, p53, and p16: Predictive biomarkers to stratify human papillomavirus associated head and neck cancer patients for de-escalation of cancer therapy.
    Ramesh PS; Devegowda D; Singh A; Thimmulappa RK
    Crit Rev Oncol Hematol; 2020 Apr; 148():102885. PubMed ID: 32062315
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Genetic patterns in head and neck cancers that contain or lack transcriptionally active human papillomavirus.
    Braakhuis BJ; Snijders PJ; Keune WJ; Meijer CJ; Ruijter-Schippers HJ; Leemans CR; Brakenhoff RH
    J Natl Cancer Inst; 2004 Jul; 96(13):998-1006. PubMed ID: 15240783
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effects of HPV-16 infection on hypopharyngeal squamous cell carcinoma and FaDu cells.
    Lu W; Feng L; Li P; Wang Y; Du Y; Chen X; Wu S; Zhao G; Lou W
    Oncol Rep; 2016 Jan; 35(1):99-106. PubMed ID: 26497405
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Human papillomavirus (HPV) 16 and the prognosis of head and neck cancer in a geographical region with a low prevalence of HPV infection.
    López RV; Levi JE; Eluf-Neto J; Koifman RJ; Koifman S; Curado MP; Michaluart-Junior P; Figueiredo DL; Saggioro FP; de Carvalho MB; Kowalski LP; Abrahão M; de Góis-Filho F; Tajara EH; Waterboer T; Boffetta P; Brennan P; Wünsch-Filho V
    Cancer Causes Control; 2014 Apr; 25(4):461-71. PubMed ID: 24474236
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Antibodies against oncoproteins E6 and E7 of human papillomavirus types 16 and 18 in patients with head-and-neck squamous-cell carcinoma.
    Zumbach K; Hoffmann M; Kahn T; Bosch F; Gottschlich S; Görögh T; Rudert H; Pawlita M
    Int J Cancer; 2000 Mar; 85(6):815-8. PubMed ID: 10709102
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Inverse relationship between human papillomavirus-16 infection and disruptive p53 gene mutations in squamous cell carcinoma of the head and neck.
    Westra WH; Taube JM; Poeta ML; Begum S; Sidransky D; Koch WM
    Clin Cancer Res; 2008 Jan; 14(2):366-9. PubMed ID: 18223210
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Systemic and local human papillomavirus 16-specific T-cell immunity in patients with head and neck cancer.
    Heusinkveld M; Goedemans R; Briet RJ; Gelderblom H; Nortier JW; Gorter A; Smit VT; Langeveld AP; Jansen JC; van der Burg SH
    Int J Cancer; 2012 Jul; 131(2):E74-85. PubMed ID: 22020783
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Degradation of p53 by human Alphapapillomavirus E6 proteins shows a stronger correlation with phylogeny than oncogenicity.
    Fu L; Van Doorslaer K; Chen Z; Ristriani T; Masson M; Travé G; Burk RD
    PLoS One; 2010 Sep; 5(9):. PubMed ID: 20862247
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.